Exos TFP Holdings’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Exos TFP Holdings’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35,970	Closed	-$363K	–	571
2022 Q4	$363K	Sell	35,970 -74	-0.2%	-$740	0.1%	183
2022 Q3	$357K	Buy	+36,044	New	+$356K	0.16%	154

Exos TFP Holdings's EBAC Position: Q1 2023 in Review

Exos TFP Holdings sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 35,970 shares — an estimated $363K sold.

Exos TFP Holdings first reported a position in EBAC in Q3 2022 and held it in 2 quarters. The position peaked at $363K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Exos TFP Holdings reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Exos TFP Holdings sold 35,970 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $363K.
Exos TFP Holdings first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q3 2022 and held it in 2 quarters.
Exos TFP Holdings's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $363K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Exos TFP Holdings's 13F filing for Q1 2023, filed 10 May 2023.